Meeting Poster

Contents

Meeting Information

[Name]

The 123rd Annual Meeting of the Japanese Dermatological Association

[Dates]

June 6(Thu.) - 9(Sun.), 2024

[Venue]

Kyoto International Conference Center
422 Iwakura Osagicho, Sakyo-ku, Kyoto, Japan 606-0001

[Committee Members]

  • President: Kenji Kabashima, M.D., Ph.D.
  • Department of Dermatology, Kyoto University Graduate School of Medicine
  • Secretary General: Saeko Nakajima, M.D., Ph.D.
  • Executive Committee Chair: Toshiya Miyake, M.D., Ph.D.

Registration

Registration fees are as follows
In principle, we accept only on-site registration. Please settle your registration fee by cash (Japanese Yen only) or credit card.

  • If you would like to online registration, please let us know by email until May 30, 2024. (JST)
JDA Member JPY 20,000
Japanese Student/
Overseas Student/Resident*
JPY 15,000
Non-Member (Company member) JPY 40,000
Non-Member (Others) JPY 25,000
Accompanying Person** JPY 3,000
  • Students and Residents need to submit their identification.
  • Students including undergraduates and postgraduates are requested to submit a proof of their status such as a photocopy of a valid student ID card or a letter from the dean, the department head or the research director with their signature.
  • The Accompanying Persons' registration fee is available only to partners and/or family members of paid delegates registered to attend the Conference. It covers the only admission for Social Gathering and Corporate Exhibition venue. Accompanying person cannot access to a lecture room.

Call for Abstracts

Submission period

From Wednesday, November 1, 2023 to Wednesday, December 6, 2023 (tentative)
Wednesday, December 20, 2023 (tentative)
Online abstract submission is now closed.

Abstract Submission Procedures

  • All abstracts must be submitted through the online abstract submission system.
  • Please see the following guidelines before proceeding to the abstract submission page. Click the button at the end of this page to submit.
  • For those who have difficulty accessing the online submission system on this website, please contact the secretariat office.

Requirements for Abstract Submission

Only one paper can be presented by the same author and/or presenter, although a presenter can be a coauthor of other papers.

[Encore abstract]

JDA annual meeting will not accept the abstract with exact same title and contents published before in other meetings and articles. JDA has this policy to avoid double publication as a fraud.
If you add a new data or information on the previous reports, we would consider to accept the abstract.

Guidelines for Writing Abstracts

[Presentation style] ※Tentative

We prepare sessions of "Oral Presentations in English" in our meeting on June 6, 2024. You can select your presentation type either of "Oral and Poster" or "Poster Only". The Local Organizing Committee will review the abstracts and decide their final presentation styles (oral and poster presentation or poster only presentation). If your abstract accepted as an oral and poster-presentation, you are kindly requested to present it orally on June 6, 2024 and also discussion it as a poster on June 6, PM or June 7, PM.
Presenters are required to come to the venue (Kyoto, Japan) and give their oral and / or poster presentation. Online presentation is not accepted.
And, presenters are required to prepare both paper and digital poster.

If your abstract is not accepted as an oral presentation, you can present it poster only.
Poster discussion is open-ended and speakers should stand-by in front of the poster at the poster discussion time (June 6, PM or June 7, PM).
And poster presenters are requested to prepare their paper and digital poster.(same data)

[Category]

Please choose from the following categories:

  1. Basic research
  2. Diagnosis
  3. Treatment
  4. Dermatopathology
  1. Dermatologic surgery
  2. Inflammatory disease
  3. Allergic disease
  4. Autoimmune disease
  1. Tumor
  2. Congenital disease
  3. Infectious disease
  4. Others

[Abstract Publication]

Your abstract will be published in the meeting program and abstract book.

[Restrictions]

  • Only abstracts submitted through the online abstract submission system will be considered.
  • Abstracts must be submitted in clear English with accurate grammar and spelling.
  • Please note that abstracts will be published as submitted, so please check carefully all names as well as spelling and grammar.

Abstract title must be 90 letters or less, including spaces.
Abstract body must be 800 letters or less, including spaces.
Up to 10 coauthors, including authors, and up to 10 affiliations may be registered.

Online Abstract Submission

Abstract Submission

  • Depending on the computer environment, there may be cases where the registrant is unable to register from the meeting web page. (e.g. Firewall is set to prevent intrusion) Please confirm your internet environment in advance.
  • It is mandatory that the registrant has an e-mail address that can be made through to him/her.
  • An e-mail will be generated automatically to inform the registrant that the abstract is registered. Please be extra careful not to mistype your e-mail address.
*If you do not receive the e-mail, the following may be the cause:

A. You can confirm your abstract from the "Confirmation & Correction" page.
- The e-mail address input was incorrect: Submission has successfully concluded. To avoid duplicated submission, do not submit more than twice. Please confirm and modify the e-mail address from the Confirmation & Correction page.

B. You cannot confirm your abstract from the "Confirmation & Correction" page.
- The submission process did not finish properly: Please submit again.

*Please do not use Gmail.
Please note that those who have registered Gmail address may not receive emails from the abstract submission system.

  • Compatible browsers are Safari version 2.0.3 (417.9.2) or above, Firefox, Microsoft Edge and Google Chrome. Do not use other browsers.

Before Submission

  • Registered data will be published on the abstract book. There will be no proofreading by the secretariat office. Please be extra careful not to mistype your abstract.
  • Change in abstract, including coauthor information, will not be accepted after the deadline. Please confirm thoroughly before submission.

Password

Before you finish your registration, you are required to enter password. Password is case sensitive and must be 4 or more characters long. Do not use passwords used for hospital information systems and e-mails.

Data Entries

<Entering symbols, Greek Letters and other special characters>
Symbols and Greek Letters must be entered using the respective codes from the list of "Abstract Body" on the Registration site. (You may cut and paste from the list.)
Follow the instructions below for special characters. These are also available on the Registration site for you to cut and paste.

  • Superscripts: <SUP></SUP>
    Example: Na<SUP>+</SUP>=Na+
  • Subscripts: <SUB></SUB>
    Example: H<SUB>2</SUB>O=H2O
  • Italics: <I></I>
    Example: <I>c-fos</I>=c-fos
  • Bold: <B></B>
    Example: <B>AAA</B>=AAA
  • Underline: <U></U>
    Example: <U>BBB</U>=BBB
  • If you wish to use "<" (less than) or ">" (greater than) in your abstract (e.g. p<0.05), to distinguish special character codes "< > "explained above from single uses of "<" or ">", enter "&gt;" for ">" and "&lt;" for "<".
    Example: p&lt;0.05=p<0.05

Complete Registration

Please confirm the contents you have input before clicking the "Confirm to submit" button.
After submission, registration number (number in the 30000s) will be automatically generated. With the registration number being generated, the abstract submission process is concluded. You will receive a confirmation mail from the system. If you do not see your registration number in the web page, please be aware that the abstract has not been accepted yet.
Please note that the secretariat office will not answer any questions related to the passwords for security purposes.

Should you have any queries on the online registration system, please contact the secretariat office.

Correction

For adding correction to registered abstracts, use the "Confirmation and Correction" button. Before the due date, confirmation and correction can be made repeatedly by inputting the registration number and password.

Abstract Submission Procedures

Submission Periods

From Wednesday, November 1, 2023 to Wednesday, December 6, 2023 (tentative)
Wednesday, December 20, 2023 (tentative)
Online abstract submission is now closed.

  • The system will automatically close after the above date. Corrections, registrations and deleting of the abstracts will not be allowed after the deadline.

Click "Abstract Submission" button when submitting your abstract for the first time.

Evaluation

All abstracts will be reviewed and presentation styles (oral and digital poster presentation or digital poster presentation only) will be decided by the Local Organizing Committee.

Notification of Accepted Abstracts

First authors will be informed of the decision of the evaluation at the address given for correspondence by early February, 2024. At that time, you will be given full details of your presentation.

Travel grants available (For the participants on site only)

A limited number of travel grants will be awarded by the Local Organizing Committee for applicants, whose abstracts have been evaluated as outstanding.
Authors wishing to be considered for a travel grant should complete the abstract submission. The nominee must be first author (i.e. presenting author) of an abstract submitted, and should provide proof of their student's or training status with a certificate of the University resp. Head of Department.
Deadline for submission of Travel grants
You are required to send a proof of their student's or training status with a certificate of the
University resp. Head of Department by Wednesday, December 6, 2023
by Wednesday, December 20, 2023
(Japan Standard Time).

Abstract Acceptance

Please check your presentation style.
If your abstract has "conflict of interest (COI)", please mention it at the beginning of your presentation and specify at your poster.
For more information, please check the heading of "Presenter's Instruction" that is scheduled to be released on this website at a later date.

Oral Presentations

The time schedule is very tight. Please keep the allotted time strictly.
5 minutes for presentation and 2 minutes for discussion.
We will inform the oral presenters how to prepare your oral presentation data soon.

Posters Presentations

*All accepted abstracts need to prepare both the paper poster and the digital poster prior to the meeting.
*All posters must be prepared in English.

[Digital poster Registration Period]
From Tuesday, April 23, 2024 to noon Wednesday, May 22, 2024.(tentative)

All of the registered poster data will be freely viewable only for JDA member and participants available for your iPads (by app).
They can check the presentation data only during meeting. (From June 6 to June 9, 2024)
Please make sure to register your poster data in advance to the congress.

[Paper poster requirements]
Poster
  • Posters should be posted on the designated board space of 180cm height and 90cm width with the abstract number of your paper.
  • Title, Author's name, Affiliation should be prepared by yourself.
  • Poster mounting and removal hours are as follows:
    Mount posters:
    June 6(Thu.) 8:00-13:00
    Remove posters:
    June 9(Sun.)14:00-16:00
    *Posters should be up all the time during the congress.
  • The poster venue is located at Kyoto International Conference Center, 1F New Hall.
  • Abstract Numbers, pins and equipment necessary for mounting posters will be prepared by the secretariat at the venue.
  • Poster discussion is open-ended. Speakers should stand by in front of the poster at the poster discussion time.
    e.g. EP1-1 → Odd number
    EP1-2 → Even number
    Abstract - Odd numbers
    June 6(Thu.) 16:15-17:45(tentative)
    Abstract - Even numbers
    June 7(Fri.) 18:10-19:10(tentative)
[Regarding Submission Numbers]

If you have forgotten your submission number, please check your email inbox for a message with the subject [JDA123] Abstract Submission Completed #submission number."
This email was sent to the email address you provided during abstract registration.

Submission Number Poster Number Oral Number Date of Oral Presentation Time of Oral Presentation Session Number of Oral Presentation Category of Poster
10003 EP12-1 - - - - Others
10012 EP6-1 - - - - Inflammatory disease
10015 EP2-1 - - - - Diagnosis
10025 EP1-1 - - - - Basic research
10029 EP6-2 E4-1 June 6(Thu.) 15:10-16:10 Oral Presentation in English 4 Inflammatory disease
10062 EP6-3 - - - - Inflammatory disease
10073 EP9-1 - - - - Tumor
10076 EP9-2 - - - - Tumor
10077 EP7-1 E1-6 June 6(Thu.) 9:00-10:00 Oral Presentation in English 1 Allergic disease
10083 EP11-1 E4-7 June 6(Thu.) 15:10-16:10 Oral Presentation in English 4 Infectious disease
10098 EP3-1 - - - - Treatment
10101 EP7-2 E1-7 June 6(Thu.) 9:00-10:00 Oral Presentation in English 1 Allergic disease
10105 EP1-2 - - - - Basic research
10115 EP11-2 E4-4 June 6(Thu.) 15:10-16:10 Oral Presentation in English 4 Infectious disease
10116 EP9-3 E2-1 June 6(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10133 EP9-4 - - - - Tumor
10141 EP7-3 E1-8 June 6(Thu.) 9:00-10:00 Oral Presentation in English 1 Allergic disease
10143 EP6-4 E4-6 June 6(Thu.) 15:10-16:10 Oral Presentation in English 4 Inflammatory disease
10148 EP9-5 - - - - Tumor
10151 EP9-6 E2-2 June 6(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10156 EP9-7 E2-3 June 6(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10158 EP8-1 - - - - Autoimmune disease
10180 EP1-3 - - - - Basic research
10192 EP10-1 - - - - Congenital disease
10207 EP9-8 - - - - Tumor
10216 EP10-2 - - - - Congenital disease
10249 EP2-2 E4-8 June 6(Thu.) 15:10-16:10 Oral Presentation in English 4 Diagnosis
10252 EP10-3 E1-4 June 6(Thu.) 9:00-10:00 Oral Presentation in English 1 Congenital disease
10256 EP12-2 - - - - Others
10262 EP8-2 E3-2 June 6(Thu.) 14:10-15:10 Oral Presentation in English 3 Autoimmune disease
10288 EP4-1 - - - - Dermatopathology
10321 EP9-9 E2-8 June 6(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10323 EP8-3 E3-3 June 6(Thu.) 14:10-15:10 Oral Presentation in English 3 Autoimmune disease
10328 EP9-10 E2-4 June 6(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
10333 EP10-4 - - - - Congenital disease
10345 EP3-2 - - - - Treatment
10347 EP3-3 - - - - Treatment
10348 EP1-4 E1-2 June 6(Thu.) 9:00-10:00 Oral Presentation in English 1 Basic research
10373 EP8-4 - - - - Autoimmune disease
10379 EP2-3 - - - - Diagnosis
10406 EP7-4 - - - - Allergic disease
10420 EP12-3 - - - - Others
10444 EP3-4 - - - - Treatment
10470 EP2-4 - - - - Diagnosis
10474 EP12-4 - - - - Others
30001 EP5-1 - - - - Dermatologic surgery
30003 EP12-5 - - - - Others
30004 EP9-11 - - - - Tumor
30005 EP2-5 E4-5 June 6(Thu.) 15:10-16:10 Oral Presentation in English 4 Diagnosis
30006 EP3-5 - - - - Treatment
30007 EP3-6 E3-5 June 6(Thu.) 14:10-15:10 Oral Presentation in English 3 Treatment
30008 EP9-12 - - - - Tumor
30009 EP9-13 E2-6 June 6(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
30010 EP6-5 E4-2 June 6(Thu.) 15:10-16:10 Oral Presentation in English 4 Inflammatory disease
30012 EP6-6 E4-3 June 6(Thu.) 15:10-16:10 Oral Presentation in English 4 Inflammatory disease
30013 EP1-5 E1-3 June 6(Thu.) 9:00-10:00 Oral Presentation in English 1 Basic research
30014 EP7-5 - - - - Allergic disease
30015 EP3-7 - - - - Treatment
30017 EP12-6 - - - - Others
30018 EP11-3 - - - - Infectious disease
30019 EP4-2 - - - - Dermatopathology
30021 EP7-6 - - - - Allergic disease
30022 EP9-14 - - - - Tumor
30023 EP5-2 - - - - Dermatologic surgery
30025 EP10-5 E1-5 June 6(Thu.) 9:00-10:00 Oral Presentation in English 1 Congenital disease
30026 EP11-4 - - - - Infectious disease
30027 EP11-5 - - - - Infectious disease
30028 EP11-6 - - - - Infectious disease
30029 EP1-6 E1-1 June 6(Thu.) 9:00-10:00 Oral Presentation in English 1 Basic research
30030 EP7-7 - - - - Allergic disease
30031 EP1-7 - - - - Basic research
30032 EP9-15 E2-5 June 6(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
30033 EP12-7 - - - - Others
30034 EP1-8 - - - - Basic research
30035 EP11-7 - - - - Infectious disease
30036 EP3-8 - - - - Treatment
30037 EP8-5 E3-6 June 6(Thu.) 14:10-15:10 Oral Presentation in English 3 Autoimmune disease
30038 EP8-6 - - - - Autoimmune disease
30039 EP9-16 E2-7 June 6(Thu.) 10:00-11:00 Oral Presentation in English 2 Tumor
30040 EP8-7 E3-4 June 6(Thu.) 14:10-15:10 Oral Presentation in English 3 Autoimmune disease
30041 EP8-8 - - - - Autoimmune disease
30042 EP8-9 - - - - Autoimmune disease
30043 EP8-10 E3-7 June 6(Thu.) 14:10-15:10 Oral Presentation in English 3 Autoimmune disease
30044 EP8-11 E3-8 June 6(Thu.) 14:10-15:10 Oral Presentation in English 3 Autoimmune disease
30045 EP3-9 E3-1 June 6(Thu.) 14:10-15:10 Oral Presentation in English 3 Treatment
見つかりませんでした

Contact us

Secretariat Office of
The 123rd Annual Meeting of the Japanese Dermatological Association
c/o The Japanese Dermatological Association
FAX : +81-3-3812-6790
E-mail : jda2024@dermatol.or.jp